Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) CEO Robert I. Blum sold 12,500 shares of Cytokinetics stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $34.90, for a total transaction of $436,250.00. Following the completion of the sale, the chief executive officer now owns 441,417 shares in […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) EVP Fady Ibraham Malik sold 2,500 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $34.86, for a total transaction of $87,150.00. Following the completion of the sale, the executive vice president now owns […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) CEO Robert I. Blum sold 12,500 shares of the stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $34.90, for a total value of $436,250.00. Following the transaction, the chief executive officer now owns 441,417 shares in the company, valued […]
Ironwood Investment Management LLC decreased its position in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 3.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,976 shares of the biopharmaceutical company’s stock after selling 1,991 shares during the quarter. […]